Antiviral Drug Development: Identification and Acquisition of Chemicals and Drugs

Abstract

During this contract period the following objectives were achieved: (1) Enhanced the database on Antiviral Drug Information System (ADIS) by the addition of critical functions including report generators and data loaders. (2) Received and registered over 2,900 compounds during the contract period. (3) Received more than 32,000 in vitro test results and incorporated them into the database. (4) A total of 4,249 samples were sent for testing. (5) Over 430 compounds were confirmed to be active in vitro. The Biological Research Faculty and Facility, Inc. (BRFF) has been able to continue expansion of elements of the antiviral drug development program centered at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). USAMRIID, a laboratory within the United States Army Medical Research and Development Command, provides the only research and development effort to discover antiviral drug candidates for use against virus-induced diseases of particular interest to DOD.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Dec 30, 1990
Accession Number
ADA237119

Entities

People

  • E. L. Stephen

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Biomedical Research
  • Contracts
  • Databases
  • Department Of Defense
  • Diseases And Disorders
  • Drug Therapy
  • Government Procurement
  • Governments
  • Identification
  • Infectious Diseases
  • Information Systems
  • Plastic Explosives
  • Procurement
  • Security
  • United States
  • Viruses

Readers

  • Child and Adolescent Substance Abuse Science in Autism Spectrum Disorders.
  • Research Science/Academic Research
  • Virology (or Medical Virology).